Kenneth Lynard new CFO of Pharming Group
02-09-2025 Kenneth Lynard has been appointed Chief Financial Officer of Pharming Group, effective 1 October 2025.
Kenneth Lynard was previously CFO at Schoeller Allibert and Zentiva. Prior to that, he held the same role at Affidea and worked, among others, at Gilead Sciences as Senior Vice President and CFO of the Global Commercial Operations, R&D, and Manufacturing divisions. He has also held several senior financial leadership positions at Medtronic, Coloplast, and Superfos.
CEO Fabrice Chouraqui is delighted to welcome Lynard: "He brings extensive financial leadership experience from both established market leaders and high-growth companies, as well as operational experience in the US and EU. His strong focus on value creation, shaped by his work with companies supported by leading private equity firms, will be invaluable as we continue to build our vision of becoming a leading global company in the field of rare diseases."